Initial human testing of an investigational vaccine co-developed by the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline plc (GSK) to prevent Ebola virus disease will begin soon
Read MoreJASO launched mass production of its PERCIUM solar cell on June 20th. The PERCIUM solar cell, the first P-TYPE solar cell in industry that surpasses a conversion efficiency of 20%, has reached an average conversion efficiency of 20.4%.
Read More